Immix Biopharma IMMX
NASDAQ IMMX
$8.34 -0.17 (-2.00%)
As of: Oct 22, 2026 · 12:22 PM EDT

Immix Biopharma (IMMX) Times Interest Earned (2021 - 2022)

Updated

Immix Biopharma's (IMMX) Times Interest Earned was -16537.12 for FY2022, compared with -7.52 in FY2021.

Analysis

Immix Biopharma (IMMX) Times Interest Earned (2021 - 2022) Analysis & Trends

  • According to Business Quant data, Times Interest Earned came in at -7.52 in FY2021 and -4.45 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,172.71 Bn 1,141.30 Bn 19.71 Bn -
2 Johnson & Johnson 643.11 Bn 561.64 Bn 17.26 Bn 25.41
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn -
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn -
5 Novartis Ag 302.74 Bn 266.73 Bn 11.24 Bn 10.28
6 Astrazeneca 268.89 Bn 242.58 Bn 12.86 Bn 7.27
7 Amgen 242.17 Bn 197.57 Bn 7.24 Bn 5.22
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn -42.08
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 Immix Biopharma 530.58 Mn 298.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -14,320.68
Mar 31, 2022 -3,427.93
Dec 31, 2021 -13.44
Sep 30, 2021 -6.45
Jun 30, 2021 -4.51
Mar 31, 2021 -5.90
API Access

Immix Biopharma Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=IMMX&period=max&api_key=YOUR_API_KEY